{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T07:12:17Z","timestamp":1648624337741},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s6665","type":"journal-article","created":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T00:01:03Z","timestamp":1284940863000},"page":"45","source":"Crossref","is-referenced-by-count":1,"title":["Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab"],"prefix":"10.2147","author":[{"given":"Francesco","family":"Patti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,8]]},"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=5195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:03:43Z","timestamp":1477850623000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/clinical-efficacy-issues-in-the-treatment-of-multiple-sclerosis-update-peer-reviewed-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ceor.s6665","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}